VIEWPOINTS PharmaShots Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020BySenior EditorDecember 28, 20200Comments
EVENTS PharmaShots Wishes you a Merry Christmas and a Happy New YearBySenior EditorDecember 24, 20200Comments
VIEWPOINTS PharmaShots Interview: Neoleukin’s Daniel-Adriano Silva Shares Insight on Novel Protein Designed to Treat or Block SARS-COV-2BySenior EditorDecember 18, 20200Comments
VIEWPOINTS PharmaShots Interview: Kezar’s Noreen Henig Shares Insight on Therapeutic Potential of KZR-616BySenior EditorDecember 17, 20200Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in November 2020BySenior EditorDecember 17, 20200Comments
VIEWPOINTS PharmaShots Interview: Cellares’ Fabian Gerlighaus Shares Insight on Cell ShuttleBySenior EditorDecember 14, 20200Comments
VIEWPOINTS PharmaShots Interview: Novocure’s William F. Doyle Shares Insight on Company’s Accomplishments in the Treatment of Glioblastoma and MesotheliomaBySenior EditorDecember 9, 20200Comments
